Zhejiang Garden Bio-chemical High-tech Co Ltd
Zhejiang Garden Biopharmaceutical Co.,Ltd. operates as a food additive and pharmaceutical manufacturing industry in China. The company provides lanolin cholesterol, vitamin A and AD3 particles, vitamin D3, 25-hydroxyvitamin D3, chemical drugs and Chinese patent medicines. It offers cholesterol; feed grade vitamin D3, refined lanolin; food additives compound nutrient fortifier SDS, CO, and MO; cho… Read more
Zhejiang Garden Bio-chemical High-tech Co Ltd (300401) - Net Assets
Latest net assets as of September 2025: CN¥3.42 Billion CNY
Based on the latest financial reports, Zhejiang Garden Bio-chemical High-tech Co Ltd (300401) has net assets worth CN¥3.42 Billion CNY as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥5.91 Billion) and total liabilities (CN¥2.50 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥3.42 Billion |
| % of Total Assets | 57.81% |
| Annual Growth Rate | 24.49% |
| 5-Year Change | 10.6% |
| 10-Year Change | 352.01% |
| Growth Volatility | 39.63 |
Zhejiang Garden Bio-chemical High-tech Co Ltd - Net Assets Trend (2007–2024)
This chart illustrates how Zhejiang Garden Bio-chemical High-tech Co Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Zhejiang Garden Bio-chemical High-tech Co Ltd (2007–2024)
The table below shows the annual net assets of Zhejiang Garden Bio-chemical High-tech Co Ltd from 2007 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥3.22 Billion | +11.24% |
| 2023-12-31 | CN¥2.89 Billion | +12.48% |
| 2022-12-31 | CN¥2.57 Billion | +12.88% |
| 2021-12-31 | CN¥2.28 Billion | -21.69% |
| 2020-12-31 | CN¥2.91 Billion | +66.94% |
| 2019-12-31 | CN¥1.74 Billion | +11.61% |
| 2018-12-31 | CN¥1.56 Billion | +21.90% |
| 2017-12-31 | CN¥1.28 Billion | +70.12% |
| 2016-12-31 | CN¥753.08 Million | +5.77% |
| 2015-12-31 | CN¥712.02 Million | +0.42% |
| 2014-12-31 | CN¥709.02 Million | +28.85% |
| 2013-12-31 | CN¥550.25 Million | +7.09% |
| 2012-12-31 | CN¥513.82 Million | +19.54% |
| 2011-12-31 | CN¥429.85 Million | +145.46% |
| 2009-12-31 | CN¥175.12 Million | +23.96% |
| 2008-12-31 | CN¥141.27 Million | +81.86% |
| 2007-12-31 | CN¥77.68 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Zhejiang Garden Bio-chemical High-tech Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 10252.8% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | CN¥2.26 Billion | 70.12% |
| Common Stock | CN¥543.47 Million | 16.89% |
| Other Components | CN¥418.08 Million | 12.99% |
| Total Equity | CN¥3.22 Billion | 100.00% |
Zhejiang Garden Bio-chemical High-tech Co Ltd Competitors by Market Cap
The table below lists competitors of Zhejiang Garden Bio-chemical High-tech Co Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Shanghai Fullhan Microelectronics Co Ltd
SHE:300613
|
$736.48 Million |
|
Cartesian Growth Corporation II Warrant
NASDAQ:RENEW
|
$736.93 Million |
|
LegalZoom.com Inc
NASDAQ:LZ
|
$736.98 Million |
|
WHA Premium Growth Freehold And Leasehold Real Estate Investment Trust
BK:WHART
|
$737.43 Million |
|
Verallia Société Anonyme
PINK:VRLAF
|
$736.19 Million |
|
Dalata Hotel Group plc
OTCGREY:DLTTF
|
$735.84 Million |
|
XD Inc
PINK:XDNCF
|
$735.71 Million |
|
Peric Special Gases Co. Ltd. A
SHG:688146
|
$735.26 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Zhejiang Garden Bio-chemical High-tech Co Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 2,893,130,267 to 3,218,400,077, a change of 325,269,810 (11.2%).
- Net income of 309,212,800 contributed positively to equity growth.
- Dividend payments of 67,393,217 reduced retained earnings.
- Share repurchases of 13,268,910 reduced equity.
- Other comprehensive income decreased equity by 115,522,859.
- Other factors increased equity by 212,241,996.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥309.21 Million | +9.61% |
| Dividends Paid | CN¥67.39 Million | -2.09% |
| Share Repurchases | CN¥13.27 Million | -0.41% |
| Other Comprehensive Income | CN¥-115.52 Million | -3.59% |
| Other Changes | CN¥212.24 Million | +6.59% |
| Total Change | CN¥- | 11.24% |
Book Value vs Market Value Analysis
This analysis compares Zhejiang Garden Bio-chemical High-tech Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.78x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 51.40x to 2.78x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2007-12-31 | CN¥0.29 | CN¥15.07 | x |
| 2008-12-31 | CN¥0.47 | CN¥15.07 | x |
| 2009-12-31 | CN¥0.51 | CN¥15.07 | x |
| 2011-12-31 | CN¥1.26 | CN¥15.07 | x |
| 2012-12-31 | CN¥1.51 | CN¥15.07 | x |
| 2013-12-31 | CN¥1.62 | CN¥15.07 | x |
| 2014-12-31 | CN¥1.75 | CN¥15.07 | x |
| 2015-12-31 | CN¥1.65 | CN¥15.07 | x |
| 2016-12-31 | CN¥1.65 | CN¥15.07 | x |
| 2017-12-31 | CN¥2.69 | CN¥15.07 | x |
| 2018-12-31 | CN¥3.25 | CN¥15.07 | x |
| 2019-12-31 | CN¥3.65 | CN¥15.07 | x |
| 2020-12-31 | CN¥5.36 | CN¥15.07 | x |
| 2021-12-31 | CN¥4.19 | CN¥15.07 | x |
| 2022-12-31 | CN¥4.73 | CN¥15.07 | x |
| 2023-12-31 | CN¥4.81 | CN¥15.07 | x |
| 2024-12-31 | CN¥5.41 | CN¥15.07 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Zhejiang Garden Bio-chemical High-tech Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 9.61%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 24.87%
- • Asset Turnover: 0.22x
- • Equity Multiplier: 1.74x
- Recent ROE (9.61%) is below the historical average (14.95%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2007 | 21.83% | 13.51% | 0.26x | 6.24x | CN¥9.19 Million |
| 2008 | 11.87% | 12.61% | 0.29x | 3.20x | CN¥2.64 Million |
| 2009 | 39.31% | 34.90% | 0.51x | 2.21x | CN¥51.34 Million |
| 2011 | 34.36% | 46.01% | 0.66x | 1.13x | CN¥104.70 Million |
| 2012 | 16.34% | 37.16% | 0.42x | 1.06x | CN¥32.59 Million |
| 2013 | 6.55% | 19.56% | 0.32x | 1.06x | CN¥-18.97 Million |
| 2014 | 5.26% | 23.47% | 0.21x | 1.07x | CN¥-33.61 Million |
| 2015 | 1.70% | 7.98% | 0.19x | 1.11x | CN¥-59.13 Million |
| 2016 | 5.81% | 13.30% | 0.38x | 1.16x | CN¥-31.53 Million |
| 2017 | 10.18% | 31.06% | 0.30x | 1.09x | CN¥2.29 Million |
| 2018 | 19.68% | 46.56% | 0.40x | 1.05x | CN¥151.24 Million |
| 2019 | 19.72% | 47.84% | 0.35x | 1.19x | CN¥169.40 Million |
| 2020 | 9.05% | 39.92% | 0.19x | 1.18x | CN¥-27.76 Million |
| 2021 | 21.23% | 43.31% | 0.32x | 1.55x | CN¥255.89 Million |
| 2022 | 14.92% | 27.07% | 0.34x | 1.61x | CN¥126.51 Million |
| 2023 | 6.65% | 17.57% | 0.21x | 1.82x | CN¥-96.96 Million |
| 2024 | 9.61% | 24.87% | 0.22x | 1.74x | CN¥-12.63 Million |
Industry Comparison
This section compares Zhejiang Garden Bio-chemical High-tech Co Ltd's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $2,123,990,643
- Average return on equity (ROE) among peers: -0.22%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Zhejiang Garden Bio-chemical High-tech Co Ltd (300401) | CN¥3.42 Billion | 21.83% | 0.73x | $736.41 Million |
| Shenzhen Neptunus Bioengineering Co Ltd (000078) | $6.47 Billion | 9.88% | 3.77x | $616.08 Million |
| Anhui Fengyuan Pharmaceutical Co Ltd (000153) | $1.18 Billion | 2.74% | 0.95x | $320.56 Million |
| Shan Dong Dong-E E-Jiao Co Ltd (000423) | $10.33 Billion | 15.07% | 0.27x | $3.03 Billion |
| Wedge Industrial Co Ltd (000534) | $298.72 Million | 1.96% | 0.38x | $1.77 Billion |
| Yunnan Baiyao Group Co Ltd (000538) | $35.11 Million | 18.13% | 0.80x | $5.62 Billion |
| Hainan Haiyao Co Ltd (000566) | $353.98 Million | -9.58% | 0.80x | $702.18 Million |
| Tus Pharmaceutical Group Co Ltd (000590) | $269.51 Million | -61.02% | 1.05x | $317.08 Million |
| Northeast Pharmaceutical Group Co Ltd (000597) | $927.49 Million | 2.65% | 1.38x | $425.60 Million |
| Jilin Aodong Pharmaceutical Group Co Ltd (000623) | $1.11 Billion | 7.32% | 0.29x | $2.05 Billion |
| Renhe Pharmacy Co Ltd (000650) | $261.49 Million | 10.60% | 0.82x | $777.45 Million |